🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Joel Greenblatt’s AXGN Holdings & Trades

First Buy
Q4 2017
Duration Held
4 Quarters
Largest Add
Q4 2017
+8,797 Shares
Current Position
6,217 Shares
$203,482 Value

Joel Greenblatt's AXGN Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 6,217 shares of Axogen, Inc. (AXGN) worth $203,482, representing 0.00% of the portfolio. First purchased in 2017-Q4, this short-term holding has been held for 4 quarters.

Based on 13F filings, Joel Greenblatt has maintained this position in AXGN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 6,217 shares. Largest reduction occurred in Q2 2018, reducing 12,500 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's Axogen (AXGN) Holding Value Over Time

Track share changes against reported price movement

Quarterly Axogen (AXGN) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +6,217 New Buy 6,217 $32.73
Q2 2018 -12,500 Sold Out 0 $0.00
Q1 2018 +3,703 Add 42.09% 12,500 $36.48
Q4 2017 +8,797 New Buy 8,797 $28.31

Joel Greenblatt's Axogen Investment FAQs

Joel Greenblatt first purchased Axogen, Inc. (AXGN) in Q4 2017, acquiring 8,797 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held Axogen, Inc. (AXGN) for 4 quarters since Q4 2017.

Joel Greenblatt's largest addition to Axogen, Inc. (AXGN) was in Q4 2017, adding 8,797 shares worth $249,000.

According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 6,217 shares of Axogen, Inc. (AXGN), valued at approximately $203,482.

As of the Q4 2025 filing, Axogen, Inc. (AXGN) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in Axogen, Inc. (AXGN) was 12,500 shares, as reported at the end of Q1 2018.